IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases (via PR Newswire)
MOUNTAIN VIEW, Calif., Dec. 3, 2012 /PRNewswire/ — IRIDEX Corporation (NASDAQ: IRIX) today announced the FDA 510(k) and CE clearance of the TxCell Scanning Laser Delivery System. The new product saves significant time in a variety of laser photocoagulation procedures in allowing physicians to…
